Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (451-460 of 533) with videos related to

Pageof 54
Sort By:
American Journal of Clinical Dermatology|November 7, 2023
Correction to: AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment HistoryLuca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara-Pinton, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaAlice Baggi, Pietro Quaglino, Marco Rubatto, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 13, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension studyMatthias Augustin, Marie Tauber, Robert Sidbury, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2020
Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
American Journal of Clinical Dermatology|September 19, 2023
AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment HistoryLuca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara-Pinton, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2022
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258]Alice Baggi, Pietro Quaglino, Marco Rubatto, et al.
Journal of the American Academy of Dermatology|January 21, 2021
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patientsAngelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio, et al.
Clinical and Experimental Dermatology|January 13, 2026
Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian StudyEleonora De Luca, Annunziata Dattola, Fabio Artosi, et al.
Pageof 54

Showing results (451-460 of 533) with videos related to

Sort By:
Pageof 54
American Journal of Clinical Dermatology|November 7, 2023
Correction to: AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment HistoryLuca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara-Pinton, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaAlice Baggi, Pietro Quaglino, Marco Rubatto, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 13, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension studyMatthias Augustin, Marie Tauber, Robert Sidbury, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2020
Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
American Journal of Clinical Dermatology|September 19, 2023
AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment HistoryLuca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara-Pinton, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2022
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258]Alice Baggi, Pietro Quaglino, Marco Rubatto, et al.
Journal of the American Academy of Dermatology|January 21, 2021
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patientsAngelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio, et al.
Clinical and Experimental Dermatology|January 13, 2026
Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian StudyEleonora De Luca, Annunziata Dattola, Fabio Artosi, et al.
Pageof 54